PointState Capital’s Juno Therapeutics, Inc. JUNO Stock Holding History

PointState Capital’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-267,600	Closed	-$12.2M	–	220
2017 Q4	$12.2M	Buy	+267,600	New	+$13.3M	0.12%	92

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

PointState Capital's JUNO Position: Q1 2018 in Review

PointState Capital sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 267,600 shares — an estimated $12.2M sold.

PointState Capital first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $12.2M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

PointState Capital reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
PointState Capital sold 267,600 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $12.2M.
PointState Capital first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
PointState Capital's Juno Therapeutics, Inc. position peaked at $12.2M in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on PointState Capital's 13F filing for Q1 2018, filed 15 May 2018.